VanEck Pharmaceutical ETF is a ETF series of VanEck ETF Trust (series S000034409). Net assets $1.3B as of 2026-03-31. Index fund.
Showing 15 of 26 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly & Co | — | $240.5M | 1869.90% |
| Novartis AG | — | $138.4M | 1076.11% |
| Merck & Co Inc | — | $124.5M | 967.94% |
| Pfizer Inc | — | $67.2M | 522.69% |
| Novo Nordisk A/S | — | $61.9M | 480.95% |
| Sanofi SA | — | $60.8M | 472.80% |
| Bristol-Myers Squibb Co | — | $59.5M | 462.47% |
| GSK PLC | — | $58.9M | 457.69% |
| AstraZeneca PLC | — | $56.6M | 439.91% |
| Johnson & Johnson | — | $55.8M | 433.76% |
| McKesson Corp | — | $54.5M | 423.60% |
| AbbVie Inc | — | $53.0M | 411.90% |
| Cencora Inc | — | $48.0M | 373.63% |
| Zoetis Inc | — | $44.7M | 347.46% |
| Haleon PLC | — | $41.4M | 321.82% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $1.3B |
| 2025-12-31 | $1.3B |
| 2025-09-30 | $545.5M |
| 2025-06-30 | $614.9M |
| 2025-03-31 | $668.7M |
| 2024-12-31 | $594.6M |
| 2024-09-30 | $721.8M |
| 2024-06-30 | $598.2M |